Immunotherapy: Considerations for Advanced Practitioners in Oncology
Develop your expertise in side effect management, recognition, and timing for immunotherapy-related adverse events for several disease states, including melanoma, non–small cell lung cancer, and urothelial carcinoma. Join the presenters as they show how to put the information into practice through case-based discussions.
This immunotherapy educational activity is sponsored by unrestricted educational grants from AstraZeneca Pharmaceuticals LP and Merck Sharp & Dohme Corp.
Error loading Partial View script (file: ~/Views/MacroPartials/JADPRO CE Faculty.cshtml)
Error loading Partial View script (file: ~/Views/MacroPartials/JADPRO CE Topic Items.cshtml)
These CME/CE/CPE certified activities are jointly provided by
 |
 |
 |
 |